Skip to main content
. 2024 Jan 2;26:2. doi: 10.1186/s13058-023-01748-8

Table 1.

Participant characteristics, including factors in the BWHS risk prediction model, by case–control status

Cases (n = 922) (%) Controls (n = 1844) (%)
First-degree family history of breast cancer
Age < 50 years
 No 275 (79.3) 575 (82.9)
 Relative diagnosed age ≥ 50 years 46 (13.3) 100 (14.4)
 Relative diagnosed age < 50 years or two relatives 26 (7.5) 19 (2.7)
Age ≥ 50 years
 No 416 (72.3) 924 (80.3)
 Relative diagnosed age ≥ 50 years 109 (19.0) 185 (16.1)
 Relative diagnosed age < 50 years or two relatives 50 (8.7) 41 (3.6)
First-degree family history of prostate cancer
 No 728 (79.0) 1509 (81.8)
 Yes 194 (21.0) 335 (18.2)
Age < 50 years
 Age at menarche < 14 years 295 (85.3) 551 (80.1)
 Age at menarche ≥ 14 years 51 (14.7) 137 (19.9)
Age ≥ 50 years
 Age at menarche < 14 years 483 (84.0) 887 (77.6)
 Age at menarche ≥ 14 years 92 (16.0) 256 (22.4)
Breastfeeding (parous women only)
 Never 382 (53.1) 840 (57.3)
 Ever 337 (46.9) 625 (42.7)
Oral contraceptive use
 Never or < 5 years 547 (59.3) 1266 (68.7)
 ≥ 5 years 375 (40.7) 578 (31.3)
Bilateral oophorectomy
 No 818 (88.7) 1625 (88.1)
 Yes 104 (11.3) 219 (11.9)
BMI at age 18 years, kg/m2
 < 25 830 (91.3) 1562 (86.3)
 ≥ 25 79 (8.7) 247 (13.7)
Premenopausal
 BMI < 30 206 (64.2) 423 (62.9)
 BMI ≥ 30 115 (35.8) 249 (37.1)
Postmenopausal
 BMI < 30 214 (57.1) 487 (58.7)
 BMI ≥ 30 161 (42.9) 342 (41.3)
Age < 50 years
 Never biopsy or benign breast disease 247 (71.2) 534 (76.9)
 Ever biopsy or benign breast disease 100 (28.8) 160 (23.1)
Age ≥ 50 years
 Never biopsy or benign breast disease 300 (52.2) 702 (61.0)
 Ever biopsy or benign breast disease 275 (47.8) 448 (39.0)
Mean age (SD) 52.7 (9.3) 52.7 (9.3)
Polygenic risk score, mean (SD) 0.23 (1.00) − 0.12 (0.98)
BWHS 5-year breast cancer risk percent, mean (SD) 1.46 (0.67) 1.32 (0.57)